002370 Stock Overview
Researches, produces, sells, and exports pharmaceutical products in China and internationally.
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
Zhejiang Yatai Pharmaceutical Co., Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥2.69 |
52 Week High | CN¥5.28 |
52 Week Low | CN¥2.21 |
Beta | 0.40 |
11 Month Change | -12.09% |
3 Month Change | 1.89% |
1 Year Change | -40.88% |
33 Year Change | -40.88% |
5 Year Change | -71.65% |
Change since IPO | -57.87% |
Recent News & Updates
Shareholder Returns
002370 | CN Pharmaceuticals | CN Market | |
---|---|---|---|
7D | -3.6% | -1.6% | -1.5% |
1Y | -40.9% | -18.2% | -21.0% |
Return vs Industry: 002370 underperformed the CN Pharmaceuticals industry which returned -18.4% over the past year.
Return vs Market: 002370 underperformed the CN Market which returned -21.4% over the past year.
Price Volatility
002370 volatility | |
---|---|
002370 Average Weekly Movement | 8.5% |
Pharmaceuticals Industry Average Movement | 5.1% |
Market Average Movement | 5.4% |
10% most volatile stocks in CN Market | 8.6% |
10% least volatile stocks in CN Market | 3.6% |
Stable Share Price: 002370's share price has been volatile over the past 3 months.
Volatility Over Time: 002370's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of CN stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1989 | 528 | Jianwei Cen | www.ytyaoye.com |
Zhejiang Yatai Pharmaceutical Co., Ltd. researches, produces, sells, and exports pharmaceutical products in China and internationally. The company offers tablets, capsules, patches, powder injections, freeze-dried powders, and troches. It also provides pharmaceutical research and development services.
Zhejiang Yatai Pharmaceutical Co., Ltd. Fundamentals Summary
002370 fundamental statistics | |
---|---|
Market cap | CN¥1.64b |
Earnings (TTM) | -CN¥26.17m |
Revenue (TTM) | CN¥421.44m |
3.9x
P/S Ratio-62.6x
P/E RatioIs 002370 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
002370 income statement (TTM) | |
---|---|
Revenue | CN¥421.44m |
Cost of Revenue | CN¥294.80m |
Gross Profit | CN¥126.64m |
Other Expenses | CN¥152.81m |
Earnings | -CN¥26.17m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -0.043 |
Gross Margin | 30.05% |
Net Profit Margin | -6.21% |
Debt/Equity Ratio | 110.0% |
How did 002370 perform over the long term?
See historical performance and comparison